Literature DB >> 10676863

Comparison of Sarns 3M heparin bonded to Duraflo II and control circuits in a porcine model: macro- and microanalysis of thrombi accumulation in circuit arterial filters.

D F Larson1, D Arzouman, L Kleinert, V Patula, S Williams.   

Abstract

Heparin-bonded perfusion circuits have been reported to reduce the thrombus formation during various levels of systemic heparinization. The goal of this study was to compare the efficacy of thrombo-resistance of the Sarns 3M heparin-bonded circuit to Baxter Duraflo II and untreated control in a porcine model. Fifteen Yorkshire pigs (60-65 kg) were anesthetized, heparinized with 3000 IU, intravenously (i.v.) and surgically cannulated with an internal jugular outflow and a femoral vein inflow. All circuits consisted of a 22-Fr venous cannula, centrifugal pump, arterial filter, an 18-Fr cannula for return and connected with equal lengths of 3/8" polyvinyl chloride tubing. The flows were maintained at 2.0 l/min for 4 h. Thrombus formation in filter samples were morphometrically analyzed through macro-densitometry, light microscopy, and scanning electron microscopy (SEM). Our findings revealed that the 3M circuit had significantly less gross thrombus (p < 0.001), 66% and 84% less microscopic thrombi and fivefold less SEM-measured aggregates (p = 0.03) compared to the Duraflo II and uncoated groups. This study demonstrated that the 3M heparin-bonded circuit had significantly reduced the formation of micro- and macro-thrombi in the minimally heparinized pig model compared to the Duraflo II and untreated control circuits.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10676863     DOI: 10.1177/026765910001500103

Source DB:  PubMed          Journal:  Perfusion        ISSN: 0267-6591            Impact factor:   1.972


  1 in total

1.  Fabrication and in vivo thrombogenicity testing of nitric oxide generating artificial lungs.

Authors:  Kagya A Amoako; Patrick J Montoya; Terry C Major; Ahmed B Suhaib; Hitesh Handa; David O Brant; Mark E Meyerhoff; Robert H Bartlett; Keith E Cook
Journal:  J Biomed Mater Res A       Date:  2013-04-24       Impact factor: 4.396

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.